Zedoarondiol is primarily studied for its anti-inflammatory and anticancer properties. It has shown potential in inhibiting the growth of certain tumor cells, particularly in breast and liver cancer lines, by inducing apoptosis and suppressing cell proliferation. Its ability to modulate signaling pathways such as NF-κB and MAPK makes it a candidate for further research in cancer therapy. Additionally, zedoarondiol exhibits antioxidant activity, which may contribute to its protective effects against cellular damage. It is also investigated for use in skincare formulations due to its anti-aging and anti-inflammatory benefits, helping reduce irritation and oxidative stress in the skin. Most applications remain in the preclinical research stage, with ongoing studies exploring its bioavailability and therapeutic efficacy.